Dyne Therapeutics (NASDAQ:DYN) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Dyne Therapeutics (DYN) operate in?

Dyne Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Dyne Therapeutics Stock (NASDAQ: DYN) stock price, news, charts, stock research, profile.

Open	$45.49
Close	$46.09
Volume / Avg.	613.34K / 1.04M
Day Range	$44.80 - $46.26
52 Wk Range	6.40 - 47.45
Market Cap	$4.63B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	59
Short Interest	8.75%
Days to Cover	7.18

Recent News

Tech Stocks Soar, Treasury Yields Fall On Cool Inflation Data; Starbucks Rockets, Chipotle Plummets: What's Driving Markets Tuesday?

A wave of bullish sentiment swept through Wall Street on Tuesday after lower-than-expected producer inflation data solidified expectations for Federal Reserve rate cuts, prompting speculators to increase bets on a more significant 50

Piero Cingari

XPeng & QuantumScape Are Among Top 11 Mid Cap Stocks That Performed Well Last Week (July 7-July 13): Details

10 mid-cap stocks jumped in last week, including QuantumScape, Lantheus Holdings, Sunrun, Kymera Therapeutics, Apogee Therapeutics, Joby Aviation, Crinetics Pharmaceuticals, Dyne Therapeutics, Summit Therapeutics, Plug Power and XPeng Inc.

Lekha Gupta

Casey's Reports Upbeat Earnings, Joins Avidity Biosciences, Rentokil Initial And Other Big Stocks Moving Higher On Wednesday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Mar

Apr

May

Jul

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Dyne Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Dyne Therapeutics Inc is a biotechnology company focused on providing therapeutics for patients with...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Dyne Therapeutics (DYN) stock?

You can purchase shares of Dyne Therapeutics (NASDAQ:DYN) through any online brokerage.

View our list of the best stock brokerages

Who are Dyne Therapeutics (DYN) competitors?

Other companies in Dyne Therapeutics’s space includes: Immunovant (NASDAQ:IMVT), IDEAYA Biosciences (NASDAQ:IDYA), Ultragenyx Pharmaceutical (NASDAQ:RARE), Avidity Biosciences (NASDAQ:RNA) and Alkermes (NASDAQ:ALKS).

What is the forecast, or price target, for Dyne Therapeutics (DYN) stock?

Dyne Therapeutics has a consensus price target of $50.60.

What is the current price for Dyne Therapeutics (DYN)?

The stock price for Dyne Therapeutics (NASDAQ: DYN) is $46.09 last updated August 30, 2024 at 4:00 PM EDT.

Does Dyne Therapeutics (DYN) pay a dividend?

There are no upcoming dividends for Dyne Therapeutics.

When is Dyne Therapeutics (NASDAQ:DYN) reporting earnings?

Dyne Therapeutics’s Q3 earnings are confirmed for Monday, October 28, 2024.

Is Dyne Therapeutics (DYN) going to split?

There is no upcoming split for Dyne Therapeutics.

What sector and industry does Dyne Therapeutics (DYN) operate in?

Dyne Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Get Our Top Trade Ideas Delivered Daily - 65% Off Now'